Treatment of Urticaria
The treatment of urticaria follows a stepwise approach, starting with standard-dose second-generation H1-antihistamines, increasing to up to 4 times the standard dose if needed, followed by omalizumab as add-on therapy for refractory cases, and cyclosporine as a third-line option. 1
First-Line Treatment
- Second-generation H1-antihistamines are recommended as first-line treatment:
- Fexofenadine 180mg
- Cetirizine 10mg
- Loratadine 10mg
- Desloratadine
- Bilastine
- Levocetirizine 1
These medications are preferred over first-generation antihistamines due to their lower sedative effects. However, first-generation antihistamines may be useful for nighttime symptoms 1.
Stepwise Management Algorithm
Step 1: Standard-dose second-generation H1-antihistamines
- Begin with standard dosing of a second-generation antihistamine
- Monitor response using validated tools like Urticaria Control Test (UCT) and Urticaria Activity Score (UAS7) 1
Step 2: Up-dosing of antihistamines
- If inadequate response to standard dose, increase to up to 4 times the standard dose
- Example: Cetirizine 10mg → 40mg daily 1
Step 3: Add-on therapies for resistant cases
Omalizumab: 300mg every 4 weeks or 600mg every 2 weeks
- FDA-approved for chronic spontaneous urticaria in adults and adolescents 12 years and older who remain symptomatic despite H1 antihistamine treatment
- Monitor for anaphylaxis risk 1
Cyclosporine: Up to 5mg/kg body weight
- Requires monitoring of blood pressure and renal function every 6 weeks
- Potential risks: hypertension, epilepsy in predisposed individuals, hirsutism, gum hypertrophy, and renal failure 1
Additional options:
Special Considerations
Acute Urticaria with Anaphylaxis
If urticaria is accompanied by signs of anaphylaxis:
- Epinephrine 0.3 mg IM in the mid-antrolateral thigh as first-line treatment 1, 3
- Combined H1+H2 blockade (typically diphenhydramine 25-50 mg IV plus ranitidine 50 mg IV) 1
- Seek immediate emergency medical attention 1
Chronic Urticaria Management
- Consider step-down only after at least 3 consecutive months of complete control
- Reduce antihistamine dose gradually (not more than 1 tablet per month) 1
- More than half of patients with chronic urticaria will have resolution or improvement of symptoms within one year 4, 2
Pediatric Patients
- Use age-appropriate dosing of second-generation H1-antihistamines
- Medication dosing must be weight-based
- Food allergies are a common cause of urticaria in infants and may require evaluation by an allergist 1
Common Pitfalls and Caveats
Trigger identification: Triggers can be identified in only 10-20% of patients with chronic urticaria, so don't delay treatment while searching for triggers 4, 2
Overuse of corticosteroids: While brief corticosteroid bursts may be used as adjunctive treatment, long-term use should be avoided due to side effects 1, 2
Limited laboratory workup: For chronic urticaria, only a simple laboratory workup is needed unless the history or physical examination suggests specific underlying conditions 4, 2
Topical doxepin limitations: If used, should be limited to 8 days and 10% of body surface area (maximum 12g daily) due to risk of allergic contact dermatitis 1
Monitoring disease control: Use validated tools like UCT and UAS7 to objectively assess treatment response rather than subjective reporting alone 1